Receptor for advanced glycation end-product in ischemia-reperfusion injury.

Ischemia-reperfusion injury (IRI) serves as a pivotal pathological mechanism underlying tissue damage in diverse clinical scenarios, particularly in organ transplantation, and cardiovascular surgery. A key factor in this process is the inflammatory response triggered by the receptor for advanced glycation end-products (RAGE). Emerging evidence reveals that dual roles of RAGE signaling: while the canonical AGEs-RAGE axis drives inflammation, RAGEexhibits ligand- and concentration-dependent pleiotropy, it is now considered a pattern recognition receptor which recognize not only a range of DAMPs, but also PAMPs, modulating divergent downstream pathways that either exacerbate or attenuate inflammatory responses. For instance, S100A6 and S100A12 as well as HMGB1, after being secreted from intracellular space, would interact with RAGE, and this kind of interaction is often indicative of pro-inflammatory effects, while some members of S100 family proteins may also exert beneficial roles in vascular remodeling and in the context of cancer. Additionally, the RAGE signaling pathway has been shown to crosstalk with other signaling networks, a topic explored further in this review. Beyond IRI and inflammatory reactions, RAGE has been implicated in a range of other diseases, positioning it as a potential therapeutic target for multiple conditions. This article provides a comprehensive assessment of RAGE and its possible involvement in the onset and progression of diseases affecting various organs and systems, while also briefly summarizing both existing and novel therapeutic targets for prevention or intervention related to RAGE.

• Publication year

  2025

• Venue

  International Immunopharmacology

• Publication date

  2025-11-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.intimp.2025.115792PMID 41207104
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppressing neuroinflammation by Shenfu injection against ischemic stroke in mice via inhibiting RAGE-PI3K-Akt pathway.

  2025cited by this paper
• Anemoside B4 targets RAGE to attenuate ferroptosis in sepsis-induced acute lung injury

  2025cited by this paper
• Shuanglu tongnao formula alleviates cerebral ischemia/reperfusion injury by rebuilding inflammatory microenvironment after cerebral ischemia.

  2025cited by this paper
• HMGB1/RAGE signaling mediates the activation of microglia and participates in depressive-like behaviors and cognitive deficits in rats after ischemia-reperfusion.

  2025cited by this paper
• Advanced glycation end products promote meniscal calcification by activating the mTOR-ATF4 positive feedback loop

  2024cited by this paper
• Cardamonin Attenuates Myocardial Ischemia/Reperfusion-Induced Ferroptosis Through Promoting STAT3 Signaling

  2024cited by this paper
• Genipin ameliorates diabetic retinopathy via the HIF-1α and AGEs-RAGE pathways.

  2024cited by this paper
• Alirocumab boosts antioxidant status and halts inflammation in rat model of sepsis-induced nephrotoxicity via modulation of Nrf2/HO-1, PCSK9/HMGB1/NF-ᴋB/NLRP3 and Fractalkine/CX3CR1 hubs.

  2024cited by this paper
• DIAPH1-MFN2 interaction decreases the endoplasmic reticulum-mitochondrial distance and promotes cardiac injury following myocardial ischemia

  2024cited by this paper
• Involvement of Mineralocorticoid Receptor Activation by High Mobility Group Box 1 and Receptor for Advanced Glycation End Products in the Development of Acute Kidney Injury

  2024cited by this paper
• RAGE/DIAPH1 Axis and Cardiometabolic Disease: From Nascent Discoveries to Therapeutic Potential.

  2024cited by this paper
• Soluble RAGE attenuates myocardial I/R injury by suppressing interleukin-6.

  2024cited by this paper
• Pivotal role of AGE-RAGE axis in brain aging with current interventions.

  2024cited by this paper
• Zhongfeng Decoction attenuates cerebral ischemia-reperfusion injury by inhibiting autophagy via regulating the AGE-RAGE signaling pathway.

  2024cited by this paper
• Engineered Macrophage Membrane‐Coated S100A9‐siRNA for Ameliorating Myocardial Ischemia‐Reperfusion Injury

  2024cited by this paper
• Cyclophilin A is a ligand for RAGE in thrombo-inflammation.

  2024cited by this paper
• Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and in vivo validation.

  2024cited by this paper
• Utilizing network pharmacology, molecular docking, and animal models to explore the therapeutic potential of the WenYang FuYuan recipe for cerebral ischemia-reperfusion injury through AGE-RAGE and NF-κB/p38MAPK signaling pathway modulation.

  2024cited by this paper
• N-acetylserotonin alleviates retinal ischemia-reperfusion injury via HMGB1/RAGE/NF-κB pathway in rats.

  2024cited by this paper
• Mechanism of Astragalus mongholicus Bunge ameliorating cerebral ischemia-reperfusion injury: Based on network pharmacology analysis and experimental verification.

  2024cited by this paper
• Network pharmacology and molecular docking elucidate potential mechanisms of Eucommia ulmoides in hepatic ischemia–reperfusion injury

  2023cited by this paper
• Hepatoprotective effects of linalool against liver ischemia-reperfusion: the role of Nrf2/HO-1/NQO1 and TLR4/RAGE/NFκB pathways.

  2023cited by this paper
• A systematic review and meta-analysis of the relationship between advanced glycation end products ceceptor (RAGE) gene polymorphisms and the risk of inflammatory bowel disease

  2023cited by this paper
• RAGE Inhibitors in Neurodegenerative Diseases

  2023cited by this paper
• Targeting HMGB1: A Potential Therapeutic Strategy for Chronic Kidney Disease

  2023cited by this paper
• Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

  2023cited by this paper
• Tetrahedral Framework Nucleic Acids Based Small Interfering RNA Targeting Receptor for Advanced Glycation End Products for Diabetic Complications Treatment.

  2023cited by this paper
• Electroacupuncture inhibits the expression of HMGB1/RAGE and alleviates injury to the primary motor cortex in rats with cerebral ischemia

  2023cited by this paper
• A Role for Advanced Glycation End Products in Molecular Ageing

  2023cited by this paper
• S100 proteins in cardiovascular diseases

  2023cited by this paper
• Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy

  2023cited by this paper
• PEG-modified nano liposomes co-deliver Apigenin and RAGE-siRNA to protect myocardial ischemia injury.

  2023cited by this paper
• QiShenYiQi pills preserve endothelial barrier integrity to mitigate sepsis-induced acute lung injury by inhibiting ferroptosis.

  2023cited by this paper
• The RAGE signaling in osteoporosis.

  2023cited by this paper
• Effect of non-enzymatic glycation on collagen nanoscale mechanisms in diabetic and age-related bone fragility

  2023cited by this paper
• S100A6: molecular function and biomarker role

  2023cited by this paper
• GLP-1/Sigma/RAGE Receptors: An evolving picture of Alzheimer's Disease pathology and treatment.

  2023cited by this paper
• Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

  2023cited by this paper
• Advanced Glycation End-Products (AGEs) Promote Endothelial Cell Pyroptosis Under Cerebral Ischemia and Hypoxia via HIF-1α-RAGE-NLRP3

  2023cited by this paper
• AGEs and RAGE: metabolic and molecular signatures of the glycation-inflammation axis in malignant or metastatic cancers

  2023cited by this paper
• Dioscin alleviates Alzheimer's disease through regulating RAGE/NOX4 mediated oxidative stress and inflammation.

  2022cited by this paper
• Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives

  2022cited by this paper
• Advanced glycation end products induce senescence of atrial myocytes and increase susceptibility of atrial fibrillation in diabetic mice

  2022cited by this paper
• The mechanism of HMGB1 secretion and release

  2022cited by this paper
• The JAK-STAT pathway at 30: Much learned, much more to do.

  2022cited by this paper
• Effects of Toxic AGEs (TAGE) on Human Health

  2022cited by this paper
• HMGB1 increases RAGE expression in vascular smooth muscle cells via ERK and p-38 MAPK-dependent pathways

  2022cited by this paper
• Identification of cross-talk pathways and ferroptosis-related genes in periodontitis and type 2 diabetes mellitus by bioinformatics analysis and experimental validation

  2022cited by this paper
• Tanshinone IIA reduces AQP4 expression and astrocyte swelling after OGD/R by inhibiting the HMGB1/RAGE/NF-κB/IL-6 pro-inflammatory axis

  2022cited by this paper
• In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration

  2022cited by this paper
• Pathophysiology of RAGE in inflammatory diseases

  2022cited by this paper
• RAGE promotes dysregulation of iron and lipid metabolism in alcoholic liver disease

  2022cited by this paper
• Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases

  2022cited by this paper
• Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease

  2021cited by this paper
• Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release.

  2021cited by this paper
• Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome

  2021cited by this paper
• RAGE-mediated T cell metabolic reprogramming shapes T cell inflammatory response after stroke

  2021cited by this paper
• Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice

  2021cited by this paper
• Knockout RAGE alleviates cardiac fibrosis through repressing endothelial-to-mesenchymal transition (EndMT) mediated by autophagy

  2021cited by this paper
• Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury

  2021cited by this paper
• Proteomics in Liver Transplantation: A Systematic Review

  2021cited by this paper
• Hypoxia and the Receptor for Advanced Glycation End Products (RAGE) Signaling in Cancer

  2021cited by this paper
• Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury

  2021cited by this paper
• Mitochondrial transplantation therapy for ischemia reperfusion injury: a systematic review of animal and human studies

  2021cited by this paper
• Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro

  2020cited by this paper
• The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding

  2020cited by this paper
• HMGB-1/RAGE signaling inhibition by dioscin attenuates hippocampal neuron damage induced by oxygen-glucose deprivation/reperfusion

  2020cited by this paper
• Targeting the receptor for advanced glycation end products (RAGE) in type 1 diabetes

  2020cited by this paper
• The Receptor for Advanced Glycation Endproducts (RAGE) Contributes to Severe Inflammatory Liver Injury in Mice

  2020cited by this paper
• Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.

  2020cited by this paper
• Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia

  2020cited by this paper
• Aucubin Attenuates Liver Ischemia-Reperfusion Injury by Inhibiting the HMGB1/TLR-4/NF-κB Signaling Pathway, Oxidative Stress, and Apoptosis

  2020cited by this paper
• RAGE and its ligands: from pathogenesis to therapeutics

  2020cited by this paper
• Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects

  2020cited by this paper
• Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health

  2019cited by this paper
• Regulated necrosis in kidney ischemia-reperfusion injury.

  2019cited by this paper
• S100 Proteins in Atherosclerosis.

  2019cited by this paper
• Effect of Advanced Glycation End‐Products (AGE) Lowering Drug ALT‐711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD‐MBD

  2019cited by this paper
• Dual faced HMGB1 plays multiple roles in cardiomyocyte senescence and cardiac inflammatory injury.

  2019cited by this paper
• The release and activity of HMGB1 in ferroptosis.

  2019cited by this paper
• HMGB1 enhances AGE-mediated VSMC proliferation via an increase in 5-LO-linked RAGE expression.

  2019cited by this paper
• Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case–control study

  2019cited by this paper
• The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases

  2018cited by this paper
• Ischemia-Reperfusion Injury Reduces Long Term Renal Graft Survival: Mechanism and Beyond

  2018cited by this paper
• Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1.

  2018cited by this paper
• Clinical and Biological Predictors of Plasma Levels of Soluble RAGE in Critically Ill Patients: Secondary Analysis of a Prospective Multicenter Observational Study

  2018cited by this paper
• RAGE-TLR Crosstalk Sustains Chronic Inflammation in Neurodegeneration

  2018cited by this paper
• Production and application of HMGB1 derived recombinant RAGE‐antagonist peptide for anti‐inflammatory therapy in acute lung injury

  2018cited by this paper
• Treating oxidative stress in heart failure: past, present and future

  2018cited by this paper
• HMGB1-RAGE signaling pathway in pPROM.

  2018cited by this paper
• Targeting RAGE Signaling in Inflammatory Disease.

  2018cited by this paper
• The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies

  2018cited by this paper
• RAGE binds preamyloid IAPP intermediates and mediates pancreatic &bgr; cell proteotoxicity

  2018cited by this paper
• Obesity associated advanced glycation end products within the human uterine cavity adversely impact endometrial function and embryo implantation competence

  2018cited by this paper
• High Mobility Group Box 1 Mediates Interferon‐γ‐Induced Phenotypic Modulation of Vascular Smooth Muscle Cells

  2017cited by this paper
• Uric Acid Induces Endothelial Dysfunction by Activating the HMGB1/RAGE Signaling Pathway

  2017cited by this paper
• RAGE-mediated extracellular matrix proteins accumulation exacerbates HySu-induced pulmonary hypertension

  2017cited by this paper
• Tissue Engineering and Regenerative Medicine Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia

  2017cited by this paper
• Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury

  2017cited by this paper
• Signal Diversity of Receptor for Advanced Glycation End Products.

  2017cited by this paper

• No citing papers are available for this paper.